Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAD52 | P43351 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18631558 | 0.88 | RAD52 (0.39) | RAD52NPSR1NAAAEPHX1TSHR | |
| SCHEMBL18655677 | 0.80 | NPSR1 (0.52) | RAD52NPSR1NAAAEPHX1TSHR | |
| SCHEMBL6236746 | 0.76 | PSMD14 (0.43) | RAD52 | |
| SCHEMBL6236836 | 0.76 | PSMD14 (0.43) | RAD52 | |
| SCHEMBL3855246 | 0.75 | NAAA (0.48) | RAD52NPSR1NAAAEPHX1TSHR | |
| SCHEMBL18632677 | 0.74 | RAD52 (0.38) | RAD52NPSR1NAAAEPHX1TSHR | |
| SCHEMBL18632659 | 0.73 | RAD52 (0.38) | RAD52NPSR1NAAAEPHX1TSHR | |
| SCHEMBL10937702 | 0.72 | PLA2G1B (0.53) | RAD52 | |
| SCHEMBL10934552 | 0.72 | PLA2G1B (0.53) | RAD52 | |
| SCHEMBL10935342 | 0.72 | PLA2G1B (0.53) | RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017048555-A1 | COMPOSITIONS COMPRISING ZWITTERIONIC ALKYL-ALKANOYLAMIDES AND/OR ALKYL ALKANOATES | JOHNSON & JOHNSON CONSUMER INC. (US) | 2017-03-23 | — | — | WO | disclosed |
| US-20170079898-A1 | COMPOSITIONS COMPRISING ZWITTERIONIC ALKYL-ALKANOYLAMIDES and/or ALKYL ALKANOATES | KENVUE BRANDS LLC | 2017-03-23 | — | — | US | disclosed |
| US-20170079898-A1 | COMPOSITIONS COMPRISING ZWITTERIONIC ALKYL-ALKANOYLAMIDES and/or ALKYL ALKANOATES | KENVUE BRANDS LLC | 2017-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170079898-A1 | COMPOSITIONS COMPRISING ZWITTERIONIC ALKYL-ALKANOYLAMIDES and/or ALKYL ALKANOATES | ANXA1, ANXA11, ANXA3 | RAD52 1527/4885NPSR1 3266/4885NAAA 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.